Income Statement

v3.8.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenues $ 260,000 $ 16,246
Operating expenses:    
Research and development costs 8,096,095 13,155,887
General and administrative expenses 5,471,010 7,497,202
Total operating expenses 13,567,105 20,653,089
Operating loss (13,307,105) (20,636,843)
Other income (expense):    
Interest income 70,269 58,835
Interest expense (159,066) (1,141,297)
Gain on related party settlement 458,608
Gain (loss) from change in fair value of liability classified warrants (1,470,174) 660,253
Fees related to issuance of liability classified warrants and other expenses (799,907) (474,167)
Total other income (expense) (2,358,878) (437,768)
Net loss $ (15,665,983) $ (21,074,611)
Net loss per common share - basic and diluted (in dollars per share) $ (1.20) $ (2.53)
Weighted average common shares outstanding - basic and diluted (in shares) 13,064,422 8,345,992
Comprehensive loss:    
Net loss $ (15,665,983) $ (21,074,611)
Foreign currency translation adjustment (1,274) 834
Comprehensive loss $ (15,667,257) $ (21,073,777)

Source